Comments
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Olanzapine tablets.
Olanzapine tablets are the generic equivalent of Eli Lilly & Company’s Zyprexa tablets. They are indicated for the treatment of serious psychotic disorders such as schizophrenia and falls under the neurological therapeutic category.
Annual sale of olanzapine was approximately $3.2 billion and it is ready for launch, the Hyderabad-based company said in a release on Wednesday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.